Document Detail

Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis.
MedLine Citation:
PMID:  14613267     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We recently reported that rheumatoid arthritis (RA) patients had increased intima-media thickness (IMT) of the common carotid artery (CCA). The present longitudinal study was performed to determine whether the change in arterial thickness was accelerated in RA patients and to determine which factor was important in the progression of arterial wall changes. METHODS: We studied 62 female RA patients with stable disease activity and 63 healthy female controls. IMT of the CCA was measured twice by high-resolution B-mode ultrasonography. The second examination was performed 18-36 months after the first, and changes were expressed as millimeters of increase per year. Baseline examinations included blood markers of inflammation and urinary calcium excretion (expressed as the calcium-to-creatinine ratio). RESULTS: RA patients showed a significantly greater increase in IMT of the CCA compared with controls. In univariate analyses of the RA patient data, the C-reactive protein (CRP) level correlated with the increase in CCA IMT. Other markers of inflammation (the erythrocyte sedimentation rate and white blood cell and platelet counts) also showed significant positive associations with the annual increase in CCA IMT in multiple regression models when adjusted for age, smoking status, blood pressure, and serum cholesterol level. The urinary calcium-to-creatinine ratio was also significantly associated with an increase in CCA IMT. Moreover, both the CRP level and the urinary calcium-to-creatinine ratio were significantly and independently associated with the increase in IMT of the CCA. CONCLUSION: Patients with RA have a higher rate of increase in thickening of the arterial wall. Inflammation and calcium mobilization are factors closely associated with the accelerated arterial wall changes.
Mayumi Nagata-Sakurai; Masaaki Inaba; Hitoshi Goto; Yasuro Kumeda; Yutaka Furumitsu; Kentaro Inui; Hidenori Koyama; Masanori Emoto; Eiji Ishimura; Tetsuo Shoji; Yoshiki Nishizawa
Related Documents :
6769187 - Hla antigens in malignant melanoma patients.
3015467 - The generation of superoxide anions by polymorphonuclear leucocytes from patients with ...
17283037 - Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abn...
23541617 - Soluble amyloid precursor protein α and β in csf in alzheimer's disease.
24868457 - Nd:yag capsulotomy after phacoemulsification in vitrectomized eyes: effects of pars pla...
18807 - Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type ii.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  48     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-12     Completed Date:  2003-12-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3061-7     Citation Subset:  AIM; IM    
Osaka City University Graduate School of Medicine, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteriosclerosis / pathology*,  ultrasonography
Arthritis, Rheumatoid / blood,  complications,  pathology*
Bone Resorption* / urine
C-Reactive Protein / analysis
Calcium / urine
Carotid Artery Diseases / etiology,  pathology*
Carotid Artery, Common / pathology
Inflammation / blood,  complications,  pathology*
Longitudinal Studies
Middle Aged
Tunica Intima / pathology
Tunica Media / pathology
Reg. No./Substance:
7440-70-2/Calcium; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coffee consumption and risk of rheumatoid arthritis.
Next Document:  Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients...